Advanced search
Publication Cover
Clinical Pharmacology: Advances and Applications Volume 6, 2014 - Issue
Submit an article Journal homepage
107
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study

Virendra Rambiritch1 Biomedical Research Ethics Committee, University of Kwazulu-Natal, Durban, KwaZulu-Natal, South Africa
,
Breminand Maharaj2 Department of Therapeutics and Medicines Management, University of Kwazulu-Natal, Durban, KwaZulu-Natal, South Africa
&
Poobalan Naidoo3 Boehringer-Ingelheim, Medical Affairs, Johannesburg, Gauteng, South AfricaCorrespondence[email protected]
Pages 63-69 | Published online: 04 Apr 2014

References

  • GroopLCGroopP-HStenmanSComparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatmentDiabetes Care1987106716783123184
  • FeldmanJMGlyburide: a second-generation sulfonyurea hypoglycemic agentPharmacotherapy1985543623923453
  • IngsRMJLawrenceJRMcDonaldAGlibenclamide pharmacokinetics in healthy volunteers: evidence for zero-order drug absorptionBr J Clin Pharmacol198213264265
  • MatsudaAKuzuyaTSugitaYKawashimaKPlasma levels of glibenclamide in diabetic patients during routine clinical administration determined by specific radioimmunoassayHorm Metab Res1983154254286416980
  • RydbergTJönssonAKarlssonMOMelanderAConcentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamicsBr J Clin Pharmacol1997433733819146849
  • KrentzAJFernerREBaileyCJComparative tolerability profiles of oral antidiabetic agentsDrug Saf1994112232417848543
  • MeierJJGallwitzBSchmidtWEMüggeANauckMAIs impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?Heart20049091214676228
  • HuizarJFGonzalezLAAldermanJSmithHSSulphonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetesJ Am Coll Cardiol2003421017102113678923
  • RambiritchVNaidooPButkowNDose-response relationships of sulphonylureas: will doubling the dose double the responseSouth Med J20071001132113617984746
  • GroopLCBarzilaiNRatheiserKDose-dependent effects of glyburide on insulin secretion and glucose uptake in humansDiabetes Care1991147247271954808
  • RobertsonLJacksonLSulphonylureas (specifically glibenclamide) and their correct dosage. Letter to the editorS Afr Med J1989762862892506654
  • RambiritchVPillaiGMaharajBRobertsonLIGlibenclamide – what dose?S Afr Med J20079747517805443
  • Hamid-AbdelMESuleimanMSEl-SayedYMNajibNMHasanMMA rapid high performance liquid chromatography assay of glibenclamide in serumJ Clin Pharm Ther1989141811882503528
  • NwaneriCCooperHBowen-JonesDMortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysisBritish Journal of Diabetes and Vascular Disease201313192207
  • JonssonAHallengrenBRydbergTMelanderAEffects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetesDiabetes Obes Metab2001340340911903411

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.